Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Fenglin Biomedical Development is a state-owned enterprise dedicated to the strategic development and management of the Fenglin Life Science Hub in the Xuhui District of Shanghai. The company serves as a central platform for the life science industry, providing essential infrastructure, investment, and business incubation services to biotech and pharmaceutical companies. It leverages the high concentration of top-tier hospitals and research institutions in the Fenglin area to foster a collaborative ecosystem for biomedical innovation. The group is instrumental in the 'Fenglin Alliance,' which coordinates resources across clinical, academic, and industrial sectors to accelerate the commercialization of medical research and drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fenglin Group.